Eloxx Pharmaceuticals, Inc. (ELOX) stock
ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$12.75−0.40 (-3.04%)
Close on Nov 16, 2026Market cap $86.56MP/E –Yield –
Eloxx Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Eloxx Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2012 was -2533.1%. For fiscal 2024 it was -49.4%, against -5062.4% the year before. The highest annual figure on record is -49.4% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -49.4% | +5013.0 |
| FY2014 | Jun 30, 2014 | -5062.4% | +73240.9 |
| FY2013 | Jun 30, 2013 | -78303.4% | −75770.3 |
| FY2012 | Jun 30, 2012 | -2533.1% | +7026.6 |
| FY2010 | Jun 30, 2010 | -9559.7% | – |
See a number that looks wrong?